Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
3 Top Stocks to Buy and Hold for the Next Decade
10:15am, Friday, 16'th Jun 2023
Brookfield boasts high-quality assets spanning wind, solar, hydroelectric, and other sustainable projects. Eli Lilly is staking out dominant positions in three huge areas: diabetes, obesity, and Alzhe
The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry
03:36pm, Thursday, 15'th Jun 2023
Biotech and pharma companies are evaluating how AI could make their businesses better. The CEO of Eli Lilly said he expects AI to massively change the productivity of the workplace.
Five things to know about berberine, the supplement being compared to the weight-loss drug Ozempic
03:32pm, Thursday, 15'th Jun 2023
By now, most Americans have heard of Ozempic, Mounjaro and Wegovy, the Type 2 diabetes drugs that are also helping people lose weight — in some cases, significant amounts.
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
02:13pm, Thursday, 15'th Jun 2023
Eli Lilly inked a gene-editing collaboration with Verve Therapeutics that gave the young biotech "pharma validation."
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:02am, Thursday, 15'th Jun 2023
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
2 Market-Beating Stocks With More Upside Potential
08:45am, Thursday, 15'th Jun 2023
Eli Lilly and Novo Nordisk are among the leaders in diabetes and obesity care. Both companies will continue to makes important strides in these two areas.
Eli Lilly CEO says Medicare price negotiations could harm drug development
03:51pm, Tuesday, 13'th Jun 2023
Ricks said the "biggest problem" with the IRA provision stems from a difference in timeline for negotiating prices on two different types of drugs.
Vast utility for weight loss drugs will more than pay for themselves, says Eli Lilly CEO David Ricks
02:34pm, Tuesday, 13'th Jun 2023
Eli Lilly CEO David Ricks joins CNBC's Bertha Coombs and 'The Exchange' live from the World Medical Innovation Forum to discuss Eli Lilly's alzheimer's treatment, concerns over coverage reimbursement
Eli Lilly and Company (LLY) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)
07:02pm, Monday, 12'th Jun 2023
Eli Lilly and Company (NYSE:LLY ) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 2023 4:20 PM ET Company Participants Anat Ashkenazi - Chief Financial Officer Conference Call Particip
2 Biotech Stocks That Could Help Make You a Fortune
07:30am, Monday, 12'th Jun 2023
CRISPR Therapeutics' fortunes may soon change for the better. Eli Lily with its strong pipeline has a favorable outlook ahead.
Johnson & Johnson Relinquishes Top Spot To Eli Lilly, Shares Undervalued Amid Technical Risks
01:23pm, Thursday, 08'th Jun 2023
Eli Lilly has surpassed Johnson & Johnson in market cap for the first time, driven by LLY's breakthroughs in obesity and Alzheimer's treatments. JNJ features a relatively less sanguine pipeline and ea
7 Growth Stocks to Sell in June Before They Crash and Burn
08:48pm, Monday, 05'th Jun 2023
Figuring out which growth stocks to sell may be the last thing on your mind right now. After all, rising hopes for a pivot on interest rates by the Federal Reserve, plus secular growth trends such as
Buy These 3 Top-Ranked ETFs and Never Sell
05:55pm, Friday, 02'nd Jun 2023
Investors seeking long-term growth and diversification often turn to Exchange-Traded Funds (ETFs) as a reliable investment option. With their unique advantages, ETFs have gained popularity among both
Eli Lilly releases new data on breast cancer, lymphoma treatments
08:03am, Friday, 02'nd Jun 2023
Eli Lilly & Co. LLY, +1.64% on Friday released new clinical trial data on treatments for certain types of early breast cancer and mantle cell lymphoma. New analysis from a late-stage trial of Verzenio
Medicare unveils plan for coverage of new Alzheimer's drugs
01:44pm, Thursday, 01'st Jun 2023
Medicare on Thursday announced plans for coverage of new Alzheimer's drugs whose accessibility has become a point of controversy.
